Literature DB >> 23723166

Immortality of cell lines: challenges and advantages of establishment.

Muhammad Irfan Maqsood1, Maryam M Matin, Ahmad Reza Bahrami, Mohammad M Ghasroldasht.   

Abstract

Cellular immortality happens upon impairment of cell-cycle checkpoint pathways (p53/p16/pRb), reactivation or up-regulation of telomerase enzyme, or upregulation of some oncogenes or oncoproteins leading to a higher rate of cell division.There are also some other factors and mechanisms involved in immortalisation, which need to be discovered. Immortalisation of cells derived from different sources and establishment of immortal cell lines has proven useful in understanding the molecular pathways governing cell developmental cascades in eukaryotic, especially human, cells. After the breakthrough of achieving the immortal cells and understanding their critical importance in the field of molecular biology, intense efforts have been dedicated to establish cell lines useful for elucidating the functions of telomerase, developmental lineage of progenitors, self-renewal potency, cellular transformation, differentiation patterns and some bioprocesses, like odontogenesis. Meanwhile, discovering the exact mechanisms of immortality, a major challenge for science yet, is believed to open new gateways toward understanding and treatment of cancer in the long term. This review summarises the methods involved in establishing immortality, its advantages and the challenges still being faced in this field.
© 2013 International Federation for Cell Biology.

Entities:  

Keywords:  cell cycle pathways; cell lines; immortalisation; pluripotency; senescence; telomerase

Mesh:

Year:  2013        PMID: 23723166     DOI: 10.1002/cbin.10137

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  41 in total

1.  Patient-derived induced pluripotent stem cells in cancer research and precision oncology.

Authors:  Eirini P Papapetrou
Journal:  Nat Med       Date:  2016-12-06       Impact factor: 53.440

2.  Extraordinarily rapid proliferation of cultured muscle satellite cells from migratory birds.

Authors:  Kevin G Young; Timothy R H Regnault; Christopher G Guglielmo
Journal:  Biol Lett       Date:  2021-08-18       Impact factor: 3.812

3.  Immortalised Cas9-expressing Cell lines for Gene interrogation.

Authors:  Luis F Malaver-Ortega; Joseph Rosenbluh
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

Review 5.  Drug screening for human genetic diseases using iPSC models.

Authors:  Matthew S Elitt; Lilianne Barbar; Paul J Tesar
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 6.  Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer.

Authors:  Bryan E Strauss; Gissele Rolemberg Oliveira Silva; Igor de Luna Vieira; Otto Luiz Dutra Cerqueira; Paulo Roberto Del Valle; Ruan Felipe Vieira Medrano; Samir Andrade Mendonça
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

Review 7.  The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development.

Authors:  Zhengying Zhou; Jinwei Zhu; Muhan Jiang; Lan Sang; Kun Hao; Hua He
Journal:  Pharmaceutics       Date:  2021-05-12       Impact factor: 6.321

Review 8.  Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies.

Authors:  Magali Seguret; Eva Vermersch; Charlène Jouve; Jean-Sébastien Hulot
Journal:  Biomedicines       Date:  2021-05-18

Review 9.  Extracellular Vesicles and Their Current Role in Cancer Immunotherapy.

Authors:  Carla Giacobino; Marta Canta; Cristina Fornaguera; Salvador Borrós; Valentina Cauda
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

10.  Establishment and characterization of a new human colon cancer cell line, PUMC-CRC1.

Authors:  Xiaocui Bian; Fang Cao; Xiaowan Wang; Yuhong Hou; Haitao Zhao; Yuqin Liu
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.